NEW YORK--(BUSINESS WIRE)--Jun 26, 2023--
Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the executive appointment of Tobias Schaefer as Chief Financial Officer (CFO). Schaefer joins Castor as a part of its organizational focus on global growth. In this role, Schaefer will oversee finance, legal and compliance, and directly influence the overall strategy, working closely with the rest of the executive team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230626426047/en/
Tobias Schaefer, Chief Financial Officer, Castor (Photo: Business Wire)
With more than 10 years of experience leading finance teams for technology companies, including CFO at Medidata Solutions, he will help shape the company’s strategic roadmap during a period of transformative growth.
"We are thrilled to welcome Tobias to our team," said Derk Arts, CEO & Founder of Castor. "His proven track record in life sciences and extensive network make him the ideal CFO for Castor. With Tobias on our management team we will continue to build momentum in our space, as we enter our next phase of growth."
Schaefer most recently served as CFO of KINEXON, a leading provider of real-time location-based connectivity, intelligence, and automation solutions. His professional journey spans over a decade, and includes various Finance leadership roles at high-profile companies including Medidata Solutions and Siemens Healthcare. His expertise in strategic planning and financial acumen will be vital in transforming Castor into a leader in clinical trial technology.
"Tobias is a visionary leader with a proven track record of guiding companies to financial success," continued Arts. "We believe his expertise will accelerate our mission to make patient-centric trials possible for everyone, anywhere in the world."
"Castor’s proven track record of growth and innovation motivated me to join the company,” said Schaefer. “I am excited to join the Castor leadership team at such a pivotal time in the company’s transformational journey. I look forward to helping the company exceed its growth and financial goals while continuing to foster a collaborative, and values-driven culture.”
About Castor
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, consent, and real-world data capture.
Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide.
For more information, visit www.castoredc.com. Follow us on LinkedIn at https://www.linkedin.com/company/castoredc
View source version on businesswire.com:https://www.businesswire.com/news/home/20230626426047/en/
CONTACT: Laura McLoughlin
Castor
laura.mcloughlin@castoredc.com
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: DATA MANAGEMENT BIOTECHNOLOGY TECHNOLOGY PROFESSIONAL SERVICES HEALTH PHARMACEUTICAL SECURITY HEALTH TECHNOLOGY LEGAL CLINICAL TRIALS FINANCE
SOURCE: Castor
Copyright Business Wire 2023.
PUB: 06/26/2023 08:00 AM/DISC: 06/26/2023 07:59 AM
http://www.businesswire.com/news/home/20230626426047/en
